section name header

Table 126-1

Therapy for Chronic Heart Failure

  1. General measures
    • Restrict salt intake
    • Avoid NSAIDs
    • Immunize against influenza and pneumococcal pneumonia
  2. Diuretics
    • Use in volume-overloaded pts
    • Weigh daily to adjust dose
    • For diuretic resistance, administer IV or use two diuretics in combination (e.g., furosemide plus metolazone)
  3. ACE inhibitor or angiotensin receptor blocker
    • For all pts with LV systolic heart failure or asymptomatic LV dysfunction
    • Contraindications: Serum K+ >5.5, advanced renal disease (e.g., creatinine >3 mg/dL), bilateral renal artery stenosis, pregnancy
  4. Beta blocker
    • For pts with symptomatic or asymptomatic heart failure and LVEF <40%, combined with ACE inhibitor and diuretics
    • Contraindications: Bronchospasm, symptomatic bradycardia or advanced heart block, unstable heart failure
  5. Aldosterone antagonist
    • Consider for class II-IV heart failure and LVEF <35%
    • Avoid if K+ >5.0 or creatinine >2.5 mg/dL
  6. Digitalis
    • For persistently symptomatic pts with systolic heart failure (especially if atrial fibrillation present) added to ACE inhibitor, diuretics, beta blocker
  7. Other measures
    • Consider combination of hydralazine and oral nitrate if not tolerant of ACE inhibitor/ARB, and as additive therapy in African-Americans
    • Consider ivabradine for LVEF 35%, if in sinus rhythm, rate >70, already on maximum tolerated beta blocker, or if contraindication to beta blocker
    • Consider ventricular resynchronization (biventricular pacemaker) for pts with class III-IV heart failure, LVEF <35%, and prolonged QRS (especially LBBB with QRS 150 msec)
    • Consider implantable cardioverter-defibrillator in pts with class II-III heart failure and ejection fraction <35%
    • Assess and treat sleep apnea

Abbreviation: LBBB, left bundle branch block.